Skip to main content
Download PDF

Black-white racial disparities in sepsis: a prospective analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort

Critical Care volume 19, Article number: 279 (2015) Cite this article

Abstract

Introduction

Sepsis is a major public health problem. Prior studies using hospital-based data describe higher rates of sepsis among black than whites participants. We sought to characterize racial differences in incident sepsis in a large cohort of adult community-dwelling adults.

Methods

We analyzed data on 29,690 participants from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. We determined the associations between race and first-infection and first-sepsis events, adjusted for participant sociodemographics, health behaviors, chronic medical conditions and biomarkers. We also determined the association between race and first-sepsis events limited to first-infection events. We contrasted participant characteristics and hospital course between black and white sepsis hospitalizations.

Results

Among eligible REGARDS participants there were 12,216 (41.1 %) black and 17,474 (58.9 %) white participants. There were 2,600 first-infection events; the incidence of first-infection events was lower for black participants than for white participants (12.10 vs. 15.76 per 1,000 person-years; adjusted HR 0.65; 95 % CI, 0.59-0.71). There were 1,526 first-sepsis events; the incidence of first-sepsis events was lower for black participants than for white participants (6.93 vs. 9.10 per 1,000 person-years, adjusted HR 0.64; 95 % CI, 0.57-0.72). When limited to first-infection events, the odds of sepsis were similar between black and white participants (adjusted OR 1.01; 95 % CI, 0.84-1.21). Among first-sepsis events, black participants were more likely to be diagnosed with severe sepsis (76.9 % vs. 71.5 %).

Conclusion

In the REGARDS cohort, black participants were less likely than white participants to experience infection and sepsis events. Further efforts should focus on elucidating the underlying reasons for these observations, which are in contrast to existing literature.

Introduction

Sepsis is a clinical disease characterized by a systemic inflammatory response to a severe infection. Sepsis is an important public health problem, responsible for more than 750,000 hospitalizations, 570,000 Emergency Department visits and 215,000 deaths annually [1]. In the United States health system, sepsis care exceeds $16.7 billion annually [1]. Sepsis survivors are at increased risk of long-term death, cognitive impairment and functional limitation [1–9].

Population-based studies have shown that black individuals have higher rates of sepsis, hospitalization mortality, and are twice more likely to develop sepsis than white individuals [3–6, 10–13]. Over a 22-year study period black participants had higher rates of sepsis than white participants [5]. Mayr et al. found that higher incidence of sepsis among black patients was attributed to higher infection-related hospitalization rates and a higher risk of acute organ dysfunction [6]. Barnato, et al. found that even while adjusting for poverty, black patients still experienced a higher population-based incidence of severe sepsis [3]. An important feature of these studies was their use of hospital discharge data for identifying sepsis events without information on initial clinical presentation or comorbid conditions. Furthermore, these studies did not distinguish hospital-acquired from community-acquired sepsis events, nor compare hospitalized sepsis patients with non-hospitalized individuals.

The REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort is one of the largest longitudinal cohorts of community-dwelling adults in the United States [14]. The objective of this study was to characterize racial differences in sepsis incidence in the REGARDS cohort.

Methods

Ethics and consent statement

The Institutional Review Board of the University of Alabama at Birmingham approved this study. We obtained informed consent from all participants of the study during baseline visit, and we also obtained consent for subsequent blood samples.

Study design and data source

We performed a prospective cohort analysis using REGARDS, one of the largest ongoing national longitudinal cohorts of community-dwelling adults in the United States [14]. Designed to evaluate geographic and black-white differences in risk factors for stroke, REGARDS recruited 30,239 black and white participants aged ≥45 years. The cohort is 45 % male and 41 % African American, and 69 % of participants are >60 years old. REGARDS recruited participants between January 2003 and October 2007. In 6-month intervals, REGARDS contacted the participants by telephone to identify any hospitalizations experienced by the participant. REGARDS personnel retrieved medical records for specific health events. REGARDS reviewed death certificates, medical records, and interviewed proxies to discern whether a participant died and the causes of the death. Further details of REGARDS study methods are described elsewhere [14].

While the objective of REGARDS was to identify and characterize stroke events, the population of REGARDS included community-dwelling adults at healthy baseline - not just individuals who had suffered a prior stroke. The REGARDS-sepsis ancillary study used the infrastructure of the parent REGARDS study to independently identify sepsis hospitalizations.

Identification of serious infection and sepsis events

We included all hospitalization events reported over a 10-year follow-up period ending December 31, 2012. The primary outcomes of this study were 1) first hospitalization for a serious infection, and 2) hospitalization for sepsis. Using the taxonomy of Angus et al., we identified all hospitalizations (Emergency Department visits and/or hospital admission) attributed by participants to a serious infection [1]. Two trained reviewers evaluated information from the corresponding medical record, confirming the presence of a serious infection based upon diagnoses documented in the Emergency Department or admission physician record. Discordances were adjudicated among abstractors, with additional physician review as needed.

Using international consensus definitions, we defined sepsis events as hospital admission for a serious infection with the presence of at least two systemic inflammatory response syndrome (SIRS) criteria, including heart rate >90 beats/minute, fever (temperature >38.3 °C or <36 °C), tachypnea (>20 breaths/minute) or PCO2 <32 mmHg, and leukocytosis (white blood cells >12,000 or <4,000 cells/mm3 or >10 % band forms) [1]. We used vital signs and laboratory test results for the initial 28 hours of hospitalization. Because of our focus on community-acquired (vs. hospital-acquired) sepsis, we did not include sepsis developing at later points during hospitalization. We did not include organ dysfunction in the definition of sepsis. Initial review of 1,349 hospital records indicated excellent inter-rater agreement for presence of serious infection (kappa = 0.92) and the presence of sepsis (kappa = 0.90) upon hospital presentation.

Participant characteristics

Participant demographics included self-reported age, race, sex, income, education, and geographic location. Health behaviors included tobacco and alcohol use. Smoking status included current, past and never. We defined alcohol use as moderate (one drink per day for women or two drinks per day for men) and heavy alcohol use (>1 drink per day for women and >2 drinks per day for men), per the National Institute on Alcohol Abuse and Alcoholism classification [15].

Baseline medical conditions included atrial fibrillation, chronic lung disease, coronary artery disease, deep vein thrombosis, diabetes, dyslipidemia, hypertension, myocardial infarction, obesity, peripheral artery disease, and stroke. We defined atrial fibrillation by participant self-report or baseline electrocardiogram (ECG) evidence of an atrial fibrillation event. Chronic lung disease was defined as participants with a history of prescribed pulmonary medication. Coronary artery disease was classified in participants with a history of heart disease (self-reported myocardial infarction (MI), coronary artery bypass graft, bypass, angioplasty, or stent) or ECG evidence. Diabetes was defined as a fasting glucose level ≥126 mg/L (or a glucose level ≥200 mg/L for those not fasting) or the use of insulin or oral hypoglycemic agents. Dyslipidemia consisted of low-density lipoprotein cholesterol >130 mg/dL, or use of lipid-lowering medications. Hypertension included systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or the reported use of antihypertensive agents. MI in participants was defined by ECG evidence or self-reports of MI in the participant’s history. Obesity was defined as body mass index (BMI) ≥30kg/m2 in addition to gender-specific waist circumference [16].

REGARDS did not collect information on pulmonary conditions such as asthma and chronic obstructive pulmonary disease. Therefore, we defined participant use of pulmonary medications as a proxy for chronic lung disease. Obtained from each participant’s medication inventory, pulmonary medications included beta-2 adrenergic agonists, leukotriene inhibitors, inhaled corticosteroids, combination inhalers, and other pulmonary medications such as ipratropium, cromolyn, aminophylline and theophylline. Other medical conditions such as; deep vein thrombosis, peripheral artery disease, and stroke were based upon self-reports.

Determination of biomarkers

Biomarkers examined in this study included serum high-sensitivity C-reactive protein (hsCRP), urinary albumin-to-creatinine ratio (ACR), Cystatin C (Cyst-C), and estimated glomerular filtration rate (eGFR). We estimated glomerular filtration (eGFR) rate using the Chronic Kidney Disease Epidemiology collaboration (CKD-EPI) equation [17]. We dichotomized all biomarkers as abnormal or normal within statistical models. We defined eGFR <60 ml/min/1.73 m2 as abnormal. Consistent with our prior study, we defined hsCRP >3.0 mg/dL as abnormal [18]. We defined Cyst-C measurements above the fourth quartile of values observed in the REGARDS cohort (≥1.1 mg/dL) as abnormal. We defined ACR ≥30 mg/g as abnormal. Further details of REGARDS biomarkers are defined elsewhere [18–20].

Hospital course

We defined hospital course as information about selected events during the hospital stay. Hospital course variables included infection type, presence of severe sepsis, sequential organ failure assessment (SOFA) for respiratory, renal hepatic, cardiovascular, hematologic, and neurologic systems, mortality in emergency department sepsis (MEDS) score, ICU admission, hospital mortality, and long-term mortality. We defined severe sepsis as the presence of sepsis and organ dysfunction.

Analysis

We compared racial differences in baseline demographics and hospital presentation characteristics using the Chi-square test for categorical characteristics, analysis of variance (ANOVA) for continuous characteristics (i.e., age), and the Kruskal-Wallis test for non-parametric continuous variables (i.e., biomarker levels). To estimate the relative rates of first infection and first sepsis in black and white participants, we fit a series of Cox proportional hazards models with time to first infection and time to first sepsis as endpoints. We censored individuals at the time of their event, death, or end of follow up (31 December 2012). We adjusted the estimates for participant sociodemographic data, health behaviors, chronic medical conditions and biomarkers. In a separate sensitivity analysis, we used the Fine and Gray model to examine all-cause mortality among all participants as a potential competing risk for sepsis events [21].

To determine the odds of sepsis among those experiencing an infection, we fit a multivariable logistic regression model assessing the association between sepsis and race, limiting the analysis to those with serious infection. We adjusted the model for sociodemographic data, health behaviors, chronic medical conditions, and biomarkers.

Due to the number of missing values for several variables (income 12.4 %, Cyst-C 6.8 %, CRP 6.4 %, albumin 4.7 %, creatinine 4.5 %), we performed the multivariable modeling with multiple imputation using chained equations (Stata MI suite), pooling regression coefficient estimates for each model across 10 imputations using Rubin’s rules [22, 23]. We used SAS version 9.4 and Stata version 13 for all analyses. We considered p values ≤0.05 statistically significant.

Results

Baseline characteristics

Among 30,239 available participants, 549 participants were excluded from analysis due to incomplete follow-up time, corresponding to 29,690 participants (Fig. 1). Among the 29,690 participants included in this analysis, there were 12,216 (41.1 %) black participants and 17,474 (58.9 %) white participants (Table 1). Black and white participants had a similar distribution of age, but black participants were more likely to be female than white participants. Black participants reported lower education and income. Tobacco use was similar between races, but black participants were less likely than white participants to use alcohol. Black participants were more likely to have a history of diabetes, hypertension, obesity and stroke. White participants were more likely to have a history of alcohol use, atrial fibrillation, chronic lung disease, coronary artery disease, dyslipidemia, and myocardial infarction.

Fig. 1
figure 1

Flowchart of participants in the Reasons for geographic and racial differences in stroke (REGARDS) study who were included in the analysis

Full size image
Table 1 Baseline characteristics of participants in the Reasons for geographic and racial differences in stroke (REGARDS) study, stratified by race
Full size table

Rates of serious infection and sepsis

There were 2,600 first-infection events over the observation period. The incidence of first-infection events was lower for black participants than those who were white (12.10 vs. 15.76 per 1,000 person-years, hazard ratio (HR) 0.77; 95 % CI, 0.71, 0.84) (Fig. 2, Table 2). The observed reduced hazard of first infection among black participants was more pronounced after adjustment for demographic data, health behaviors, chronic medical conditions, and biomarkers (adjusted HR 0.65; 95 % CI, 0.59, 0.71) (Fig. 2, Table 2).

Fig. 2
figure 2

Kaplan-Meier plot for time to first-infection event, stratified by race

Full size image
Table 2 Association between race and first-infection and first-sepsis events
Full size table

Among study participants there were 1,526 first-sepsis events over the observation period. The incidence of first-sepsis events was lower for black participants than white participants (6.93 vs. 9.10 per 1,000 person-years, HR 0.76; 95 % CI, 0.69, 0.85) (Fig. 3, Table 2). Similar to results for infection, the association was more pronounced after adjustment for demographics, health behaviors, chronic medical conditions, and biomarkers (adjusted HR 0.64; 95 % CI, 0.57, 0.72) (Fig. 3, Table 2).

Fig. 3
figure 3

Kaplan-Meier plot for time to first sepsis, stratified by race

Full size image

Among the 2,600 first-infection events, 1,389 fulfilled sepsis criteria. Limited to the first-infection participants, the odds ratio (OR) for sepsis was similar between races (OR 1.01; 95 % CI, 0.86, 1.19). This association did not change after adjustment for confounders (adjusted OR 1.01; 95 % CI, 0.84, 1.21).

Hospital presentation and course

Within the 2,600 first-infection events, infection types, severe sepsis frequency, SOFA scores, MEDS scores, ICU admission, hospital mortality, and long-term mortality were similar in black and white participants (Table 3). Among 1,526 first-sepsis events, black participants had higher proportions of severe sepsis and slightly higher SOFA scores (Table 4). Infection types, MEDS scores, ICU admission, hospital mortality and long-term mortality were similar in black and white participants.

Table 3 Hospital presentation and course for first-infection events stratified by race
Full size table
Table 4 Hospital presentation and course for first-sepsis events stratified by race
Full size table

Sensitivity analysis

When accounting for all-cause mortality as a competing risk, the increased rates of sepsis among white participants persisted (adjusted sub-HR 0.66; 95 % CI, 0.57, 0.75) (Fig. 4).

Fig. 4
figure 4

Competing Risks Analysis: Cumulative incidence function and adjusted sub-hazard ratio, stratified by race

Full size image

Discussion

Prior epidemiological studies using hospital discharge data have reported higher incidence of sepsis and severe sepsis among black patients compared to those who were white (Table 5) [3–6, 10–13]. However, in this population-based study of community-dwelling adults in the REGARDS cohort, we found that black participants were at lower risk of developing sepsis than white participants. This contrasting racial disparity appeared to be due to lower rates of hospitalization for a serious infection. Once hospitalized for a serious infection, the odds of sepsis were similar in black and white participants. Among those hospitalized for sepsis, black participants were slightly more likely have severe sepsis, but other aspects of the hospital course were similar between races.

Table 5 Association between sepsis and race as determined in eight studies
Full size table

The differences in observed race-sepsis associations between the current and prior studies could be explained by differences in the identification of sepsis events. Previous studies have applied ICD-9 taxonomies of Martin, et al. and Angus, et al. in order to identify sepsis and severe sepsis hospitalizations (Table 5) [3–6, 10–13]. This approach could lead to documentation bias, and research suggests that the use of discharge diagnoses tends to have poor sensitivity to detect sepsis [24, 26]. For example, a recent study concluded that ICD-9 discharge diagnoses were highly specific (94.6 %) but had poor sensitivity (27.6 %) for detecting community-acquired sepsis events. [26]. Due to the fact that present-on-admission flags are not commonly available in discharge datasets used for research purposes, prior sepsis studies were also unable to disentangle early community-acquired sepsis from later hospital-acquired sepsis. Moreover, documentation bias is plausible if physicians were more likely to record sepsis, infection and organ dysfunction diagnoses based on the patient’s race.

In contrast to prior work, our study employed comprehensive chart review in the definition of sepsis events. By using a definition that encompassed laboratory measurements and documentation of an infection, it is plausible that differences in sepsis detection could be attributable to hospital or ED practices. Specifically, patterns of initial diagnostic testing may have varied between black and white participants based on the site of presentation, leading to differing rates of sepsis. This assertion is supported by prior research, which indicates that black patients receive inferior care, such as lower quality and intensity of care [27]. Although we were not able to explore differences in hospital quality in the current analysis, this is an intriguing area of future research.

Studies performed across a wide range of disciplines indicate that impaired access to care or healthcare status causes delayed hospital presentation among African Americans compared to other races [27–30]. An interesting question is whether white participants may have had better access to quality outpatient infection care than black participants, with only those with more serious illness presenting to the hospital for care. This hypothesis is tempered by the fact that we observed similar SOFA and MEDS scores between races. The contrasting findings between the current and prior studies may have also occurred if black participants were more likely than white participants to develop hospital-acquired sepsis. Mayr, et al. (2010) found that black participants were more likely to develop postoperative infections than their white counterparts, which would support this hypothesis [6]. Because of our focus on community-acquired sepsis, we did not examine the later parts of the hospital course to identify the development of hospital-acquired sepsis.

Racial disparities are important because they may reflect differences in biological response, genetics, health behaviors, or access to or quality of medical care. Studies of hepatitis C virus and coronary heart disease have affirmed the presence of racial disparities due to differences in all of these domains [31–33]. In the national effort to reduce sepsis morbidity and mortality, racial differences might shed light on the pathophysiologic or clinical factors that influence sepsis outcomes. Some may view our results as negating the need for scrutinizing racial disparities. On the contrary, our findings - especially as they contrast with prior studies - signal the need to more intensely explore racial differences.

Limitations

REGARDS is a longitudinal study intended to investigate stroke, and not sepsis outcomes. The current analysis is not a surveillance study, and thus we may not have achieved complete ascertainment of all sepsis events. Recall bias is a limitation, and therefore the number of sepsis events identified may be underestimates. By design, the REGARDS cohort includes only African Americans and white Americans, and thus these results may not be generalizable to other ethnic groups. REGARDS oversampled black participants in the southeastern US, potentially limiting generalizability to other populations.

Selection bias or participation bias are potential limitations of this study. By design, the REGARDS cohort contains individuals over 45 years old only; sepsis rates and the observed associations may have differed for younger individuals. Thus, it is possible that black participants may have experienced more sepsis-related events at younger ages than white participants, an observation made in previous research [4]. Participants may have been less likely to participate in the baseline visit of study based on work status (i.e., black men were less likely to participate). This is largely explained by required blood management visits at baseline during morning weekdays, which may have alternatively required missed workdays. However, this is likely an equal burden for all race-sex strata, but could have been more prevalent for black men. We identified individuals who presented to the hospital with sepsis, but did not include those who acquired sepsis during their hospitalization. Participants in the REGARDS cohort could be significantly different from prior studied populations. However, previous studies investigating the REGARDS cohort have observed racial differences consistent with other cohorts; for example, black participants having higher risk of fatal coronary heart disease than white participants [32].

REGARDS did not have information on vaccination, so we could not ascertain if racial differences in vaccinations may have resulted in different infection rates. Prior research suggests that black patients have a higher incidence of infections (e.g., bacteremic pneumonia) than white patients [34, 35]. Robinson, et al. explained that the racial disparity could be attributed to lower vaccination rates among black patients [35]. Furthermore, an additional study found that after the introduction of the pneumococcal vaccine, the disparity between black and white participants diminished [36].

Conclusion

In conclusion, in the national REGARDS cohort, black participants were less likely than white participants to experience infection and sepsis events. However, after hospitalization for first infection there were no racial differences in the odds of sepsis. Further efforts should focus on elucidating the underlying reasons for these observations, which are in contrast to existing literature.

Key messages

  • In the REGARDS cohort, the long-term risk of community-acquired sepsis is higher in white participants than in black participants.

  • In this study, white participants were more likely to develop both infection and sepsis.

  • Among those with first infections, the odds of sepsis were not different between black and white participants.

Abbreviations

ACR:

albumin-to-creatinine ratio

BMI:

body mass index

CKD-EPI:

Chronic Kidney Disease Epidemiology Collaboration equation

CRP:

C-reactive protein

Cyst-C:

Cystatin-C

ECG:

electrocardiogram

eGFR:

estimated glomerular filtration rate

HR:

hazard ratio

MEDS:

mortality in emergency department

MI:

myocardial infarction

OR:

odds ratio

REGARDS:

Reasons for geographic and racial differences in stroke

SIRS:

systemic inflammatory response syndrome

SOFA:

sequential organ failure assessment

WC:

waist circumference

References

  1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–10.

    Article  CAS  PubMed  Google Scholar 

  2. Angus DC. The lingering consequences of sepsis: A hidden public health disaster? JAMA. 2010;304:1833–4.

    Article  CAS  PubMed  Google Scholar 

  3. Barnato AE, Alexander SL, Linde-Zwirble WT, Angus DC. Racial variation in the incidence, care, and outcomes or severe sepsis: analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med. 2008;177:279–84.

    Article  PubMed  Google Scholar 

  4. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Occurrence and outcomes of sepsis: influence of race. Crit Care Med. 2007;35:763–8.

    Article  PubMed  Google Scholar 

  5. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–54.

    Article  PubMed  Google Scholar 

  6. Mayr FB, Yende S, Linde-Zwirble WT, Peck-Pamler OM, Weissfeld LA, Angus DC. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA. 2010;303:2495–503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5:4–11.

    Article  PubMed  Google Scholar 

  8. Wang HE, Shapiro NI, Angus DC, Yealy DM. National estimates of severe sepsis in United States emergency departments. Crit Care Med. 2007;35:1928–36.

    Article  PubMed  Google Scholar 

  9. Wang HE, Devereaux RS, Yealy DM, Safford MM, Howard G. National variation in United States sepsis mortality: a descriptive study. Int J Health Geogr. 2010;9:1–9.

    Article  CAS  Google Scholar 

  10. Baine W, Yu W, Summe JP. The epidemiology of hospitalization of elderly Americans for septicemia or bacteremia in 1991-1998. Application of Medicare claims data. Ann Epidemiol. 2001;11:118–26.

    Article  CAS  PubMed  Google Scholar 

  11. Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS. The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med. 2006;34:2576–82.

    Article  PubMed  PubMed Central  Google Scholar 

  12. McBean M, Rajamani S. Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1997. J Infect Dis. 2001;183:596–603.

    Article  CAS  PubMed  Google Scholar 

  13. Richardus JH, Kunst AE. Black-white differences in infectious disease mortality in the United States. Am J Public Health. 2001;91:1251–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25:135–43.

    Article  PubMed  Google Scholar 

  15. Willenbring ML, Massey SH, Gardner MB. Helping patients who drink too much: an evidence-based guide for primary care clinicians. Am Fam Physician. 2009;80:44–50.

    PubMed  Google Scholar 

  16. Navaranjan D, Rosella LC, Kwong JC, Campitelli M, Crowcroft N. Ethnic disparities in acquiring 2009 pandemic H1N1 influenza: a case-control study. BMC Public Health. 2014;14:214.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Gotch FA, Kotanko P, Thijssen S, Levin NW. The KDIGO guideline for dialysate calcium will result in an increased incidence of calcium accumulation in hemodialysis patients. Kidney Int. 2010;78:343–50.

    Article  CAS  PubMed  Google Scholar 

  18. Wang H, Shapiro N, Safford MM, Griffin R, Judd S, Rodgers JB, et al. High-sensitivity C-reactive protein and risk of sepsis. PLoS One. 2013;8:e69232.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Powell TC, Donnelly JP, Gutierrez OM, Griffin RL, Safford MM, Wang HE. Cystatin C and long term risk of community-acquired sepsis: a population-based cohort study. BMC Nephrol. 2015;16:10.

    Article  Google Scholar 

  20. Wang HE, Shapiro NI, Griffin R, Safford MM, Judd S, Howard G. Inflammatory and endothelial activation biomarkers and risk of sepsis: a nested case-control study. J Crit Care. 2012;28:549–55.

    Article  CAS  Google Scholar 

  21. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509.

    Article  Google Scholar 

  22. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10:585–98.

    Article  CAS  PubMed  Google Scholar 

  23. Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc. 1996;91:473–89.

    Article  Google Scholar 

  24. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304:1787–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Jolley RJ, Sawka KJ, Yergens DW, Quan H, Jette N, Doig CJ. Validity of adminstrative data in recording sepsis: a systematic review. Crit Care. 2015;19:12.

    Article  Google Scholar 

  26. Wang HE, Addis DR, Donnelly JP, Shapiro NI, Griffin RL, Safford MM, et al. Discharge diagnoses versus medical record review in the identification of community-acquired sepsis. Crit Care. 2015;19:11.

    Article  Google Scholar 

  27. Vogel T. Update and review of racial disparities in sepsis. Surg Infect (Larchmt). 2012;13:203–8.

    Article  Google Scholar 

  28. O'Brien JM, Lu B, Ali NA, Levine DA, Aberegg SK, Lemeshow S. Insurance type and sepsis-associated hospitalizations and sepsis-assocated mortality among US adults: A retrospective cohort study. Crit Care. 2011;15:11.

    Article  Google Scholar 

  29. Parikh AA, Robinson J, Zaydfudim VM, Penson D, Whiteside MA. The effect of health insurance status on the treatment and outcomes of patients with colorectal cancer. J Surg Oncol. 2014;110:227–32.

    Article  PubMed  Google Scholar 

  30. Oramasionwu CU, Brown CM, Ryan L, Lawson KA, Hunter JM, Frei CR. HIV/AIDS disparities: the mounting epidemic plaguing US Blacks. J Natl Med Assoc. 2009;101:1196–204.

    Article  PubMed  Google Scholar 

  31. Soto GJ, Martin GS, Gong MN. Healthcare disparities in critical illness. Crit Care Med. 2013;41:2784–93.

    Article  PubMed  Google Scholar 

  32. Safford MM, Brown TM, Muntner P, Durant RW, Glasser S, Halanych JH, et al. Association of race and sex with risk of incident acute coronary heart disease events. JAMA. 2012;308:1768–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Liu G, Holmberg SD, Kamili S, Xu F. Racial disparities in the proportion of current, unresolved hepatitis c virus infections in the United States, 2003-2010. Dig Dis Sci. 2014;59:1950–7.

    Article  PubMed  Google Scholar 

  34. Burton DC, Flannery B, Bennett NM, Farley MM, Gershman K, Harrison LH, et al. Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among U.S. adults. Res Pract. 2010;100:1904–11.

    Google Scholar 

  35. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, et al. Epidemiology of invasive streptococcus pneumoniae infections in the united states, 1995-1998. JAMA. 2001;285:1729–35.

    Article  CAS  PubMed  Google Scholar 

  36. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, et al. Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J. 2004;23:726–31.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by award R01-NR012726 from the National Institute for Nursing Research, UL1-RR025777 from the National Center for Research Resources, and by grants from the Center for Clinical and Translational Science and the Lister Hill Center for Health Policy of the University of Alabama at Birmingham. The parent REGARDS study was supported by cooperative agreement U01-NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. Representatives of the funding agencies have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data. The authors thank the other investigators, the staff, and the participants of the REGARDS study for their valuable contributions. A full list of participating REGARDS investigators and institutions can be found at http://www.regardsstudy.org and http://www.regardssepsis.org. Mr Donnelly received support from the Agency for Healthcare Research and Quality, Rockville, Maryland (T32-HS013852).

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, University of Alabama School of Medicine, 619 19th Street South, OHB 251, Birmingham, AL, 35249, USA

    Justin Xavier Moore, John P. Donnelly & Henry E. Wang

  2. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA

    Justin Xavier Moore, John P. Donnelly & Russell Griffin

  3. Division of Preventive Medicine, Department of Medicine, University of Alabama School of Medicine, Birmingham, Alabama, USA

    John P. Donnelly & Monika M. Safford

  4. Division of Infectious Diseases, Department of Medicine, University of Alabama School of Medicine, Birmingham, Alabama, USA

    John Baddley

  5. Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, USA

    George Howard

Authors
  1. Justin Xavier Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John P. Donnelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Russell Griffin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Monika M. Safford
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. George Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John Baddley
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Henry E. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Henry E. Wang.

Additional information

Competing interest

Dr Safford reports the following potential conflicts of interest: Amgen - salary support to study patterns of statin use in Medicare and other large databases; diaDexus - salary support for a research grant on lipids and CHD outcomes; diaDexus - consulting to help with FDA application; NIH, AHRQ - salary support for research grants. Mr Moore, Mr Donnelly and Drs, Griffin, Wang, Howard, and Baddley do not report any related conflicts of interest.

Authors’ contributions

JXM was involved in the conception of the study, participated in the design of the study, performed statistical analysis and interpretation of the data, and drafted the manuscript. JPD participated in the design of the study and participated in the statistical analysis. RG participated in the design of the study and participated in the statistical analysis. MMS was involved in the conception of the study and participated in the design of the study. GH was involved in the conception of the study and participated in the design of the study. JB was involved in the conception of the study and participated in the design of the study. HEW was involved in the conception of the study, participated in the design of the study, participated in the statistical analysis and interpretation of the data, and helped to draft the manuscript. All authors revised the manuscript critically for important intellectual content, gave final approval of the version to be published, and take responsibility for the integrity of the data and the accuracy of the data analysis.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moore, J.X., Donnelly, J.P., Griffin, R. et al. Black-white racial disparities in sepsis: a prospective analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. Crit Care 19, 279 (2015). https://0-doi-org.brum.beds.ac.uk/10.1186/s13054-015-0992-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s13054-015-0992-8

Keywords

Critical Care

ISSN: 1364-8535